Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added UI elements and labels: Show glossary and Hide glossary, and updated metadata fields with 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus Revision: v3.4.0. Removed or replaced older labels: 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.4%
    Check dated 2026-01-23T10:17:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing Revision: v3.3.3. No substantive content or layout changes are evident.
    Difference
    0.1%
    Check dated 2026-01-16T06:40:06.000Z thumbnail image
  4. Check
    50 days ago
    Change Detected
    Summary
    Added Minnesota as a location under the Locations section and removed the HHS Vulnerability Disclosure text/link from the footer.
    Difference
    0.2%
    Check dated 2025-12-18T12:24:07.000Z thumbnail image
  5. Check
    73 days ago
    Change Detected
    Summary
    Added: a note that publications are automatically filled from PubMed and may not be about the study, and a new revision tag (v3.3.2); removed the older PubMed-origin text and the earlier revision tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:48:44.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    Removed a general government funding status notice from the page. The notice previously informed users about potential delays and updates due to funding and operating status of NIH facilities.
    Difference
    0.4%
    Check dated 2025-11-18T06:57:57.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The new version shows minor UI and formatting updates with no changes to the study's core details (eligibility, outcomes, dosing, or locations).
    Difference
    0.4%
    Check dated 2025-11-03T20:58:46.000Z thumbnail image

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.